Montreal Neurological Institute news
Discovery expands our understanding of how we remember sound The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.
Have you ever met someone who just wasn’t into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population. Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of McGill University have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.
KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC
KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel Alzheimer’s treatment in Canada that the parties have been co- developing since 2015. The treatment, a biologic molecule made up of a peptide that fights Alzheimer’s and an antibody-based carrier molecule designed to shuttle the peptide into the brain, is a custom- engineered therapeutic developed at NRC.
McGill Newsroom Chemicals found to improve low-light vision of tadpoles by sensitizing retinal cells A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
McGill Newsroom Research underlines importance of computational power in future neurological breakthrough Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.
McGill Newsroom Couche-Tard founder gives $4 million to McGill for groundbreaking research on intellectual disabilities
McGill Newsroom It’s all math: How Professor Alan Evans is using cutting-edge statistics to unravel the complexity of brain disorders. When Alan Evans was starting out in the 1970s, researchers didn’t ask the boss to foot their bar tab. But that’s exactly what some of the coders in his Montreal Neurological Institute lab recently proposed: a 9-to-5 Saturday hackathon, held in an Irish pub a few blocks from the McGill University campus.
Raising awareness about stroke Every ten minutes, someone in Canada suffers a stroke. Strokes kill 14,000 Canadians each year, making stroke the third leading cause of death in this country. The Montreal Neurological Institute and Hospital (The Neuro) hopes to increase public awareness about the dangers of stroke by marking Stroke Month. People who learn about the causes of stroke can take measures to reduce their chances of having a stroke. What is a stroke?
By the Media Relations Office, McGill Newsroom Spotlight on neurosciences Neuroinformatics stands at the intersection of neuroscience and information science. One of the world leaders in this discipline is Prof. Pedro Valdes-Sosa, General Vice-Director for Research of the Cuban Neuroscience Center (CNEURO) which he co-founded in 1990.
The Montreal Neurological Institute and Hospital (the Neuro) in Canada to conduct a radical experiment in open science. Nature
The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
By Katherine Gombay, McGill Newsroom New technique offers potential to reconnect neurons of people with central nervous system damage
Research also demonstrates brain's plasticity and ability to adapt to new language environments
A new study led by researchers at the Montreal Neurological Institute and Hospital of McGill University and the MUHC, gets closer to identifying the mechanisms responsible for multiple sclerosis and makes headway in the search for better treatments.
Dr. Alan Evans, James McGill Professor of Neurology and Neurosurgery, Psychiatry and Biomedical Engineering at the Montreal Neurological Institute, McGill University has been named a Fellow of the Royal Society of Canada (RSC). He is one fourteen new RSC Fellows from McGill University, including McGill Principal Suzanne Fortier. The induction ceremony will take place on Friday, November 27 in Victoria, B.C.